About
Responsibility
Partnering
Investors
News
Careers
Contact

News

Refine by category
Refine by year
- 2019
- 2018
- Archive

Press Releases —

ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe

27 Nov 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results

07 Nov 2019

Third quarter 2019 revenue of $120 million Third quarter 2019 net loss of $119 million Third quarter 2019
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results

24 Oct 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

07 Aug 2019

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 20
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin

25 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results

24 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Industry Related —

Industry Related category item

25 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders

17 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or the "Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more

Featured News

Get up-to-date news direct to your inbox.

Name

Email

ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

07 Aug 2019

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 20
Learn more
ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders

17 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or the "Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

04 Jan 2019

Company acquires international rights to Salagen® tablets (pilocarpine hydrochloride) (excluding Japan ri
Learn more

About
Responsibility
Partnering
Investors
News
Careers
Contact

Articles & By-laws
Ethics & Transparency
Modern Slavery Statement

Terms & Conditions
Privacy Policy
Recruitment Scams

Follow us on LinkedIn

Copyright 2019 Advanz Pharmaceutical®. All Rights Reserved